药物遗传检测或治疗药物监测:一个定量框架
Maddalena Centanni1, Niels Reijnhout1, Abel Thijs2
1Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden.
Clinical pharmacokinetics
|June 6, 2024
概括
药物遗传学分析优于治疗药物监测 (TDM) 在特定情况下估计药物暴露,特别是当个体间变异性较低而其他变异性较高时. 对于具有较低残留和间偶变性的药物,TDM仍然是最好的.
科学领域:
- 药物动力学和药物基因组学
- 临床药理学 临床药理学
- 药物的新陈代谢和处置
背景情况:
- 药物暴露的个体间变异性 (IIV) 需要个性化剂量策略.
- 药物遗传学分析和治疗药物监测 (TDM) 是管理这种变化的关键方法.
- 估计药物暴露的最佳策略因药物和变化源而异.
研究的目的:
- 量化评估何时药物遗传学分析在估计药物暴露时优于TDM.
- 调查IIV,间场变性 (IOV) 和残余不明原因变性 (RUV) 对每个方法的性能的影响.
- 为药物剂量个性化提供支持临床决策的数据.
主要方法:
- 从药物文学中选择的药物动力学模型,包括药物遗传学和TDM考虑.
- 在IIV,IOV和RUV的不同水平下,模拟的药物暴露 (深度度或AUC)
- 在六个药物病例中比较了药物遗传学概况与TDM的预测性能.
主要成果:
- 药物遗传学分析对TDM的优越性因药物而异:5-甲 (100%),温克里斯 (49.6%),RISPERIDONE (48.1%),埃法维伦兹 (49.2%),塔莫西芬 (12.7%) 和塔克罗利斯 (11.0%).
- 当无法解释的IIV高,而RUV/IOV低时,TDM优越.
- 当无法解释的IIV较低,IOV/RUV较高时,药物遗传学分析是首选的.
结论:
- 对于具有较低RUV和IOV的药物 (例如,他莫西芬,塔克罗利斯),TDM提供了最佳的暴露估计.
- 对于低无法解释的IIV和高RUV的药物 (例如,efavirenz,5-FU),对于大多数患者来说,药物遗传学概况更准确.
- 诸如基因型患病率,对PK的遗传影响以及TDM估计AUC的能力等因素影响了策略的选择.
相关概念视频
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Drug Administration and Therapy Phases: Overview
448
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
448
Pharmacovigilance
825
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
825
Pharmacodynamics: Overview and Principles
1.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.1K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Pharmacokinetic Models: Overview
653
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
653


